The Top 5 Myths About eCOAs In 2025

Electronic Clinical Outcome Assessments (eCOAs) have advanced considerably, yet persistent myths still prevent clinical teams from leveraging their full value. As regulatory expectations evolve and pressure mounts for greater trial efficiency, overcoming these misconceptions is more critical than ever. A recent analysis by the Partnership for Advancing Clinical Trials (PACT) found that eCOAs are the most commonly implemented decentralized clinical trial (DCT) tool, though not all solutions offer the same quality or flexibility.

This session, designed for both those new to eCOA and those aiming to enhance its impact across their R&D portfolios, features expert insights that debunk the top five eCOA myths of 2025. Attendees will learn the truth about implementation costs and timelines, discover how to maximize patient adherence while minimizing burden on sites and participants, and explore why modern eCOA technologies are now easier to integrate than ever before.